Dare Bioscience (DARE) vs Rocket One (RKTO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Rocket One (RKTO) has outperformed Dare Bioscience (DARE) over the past year, losing 59.1% versus a loss of 66.3%. Over five years, DARE leads with a -95.9% price change compared with -97.8% for RKTO. Rocket One is the larger company by market cap ($16.5 million vs $15.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DARE | RKTO |
|---|---|---|
| Share price | $0.7812 | $0.6646 |
| Market cap | $15.37M | $16.55M |
| 1-day change | +1.17% | +2.87% |
| YTD return | -59.99% | -34.74% |
| 1-year return | -66.28% | -59.11% |
| 5-year return | -95.90% | -97.77% |
| EPS (TTM) | $-0.71 | $-0.82 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.78 | $2.45 |
| 52-week low | $0.69 | $0.489 |
| Distance from 52-week high | -79.33% | -72.87% |
| Analyst consensus | none | — |
| Avg. price target upside | +966.31% | — |
| Average volume | 525.06K | 630.66K |
| Shares outstanding | 19.67M | 24.90M |
| Employees | 21 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Dare Bioscience
DARE stock →Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 21 employees
About Rocket One
RKTO stock →Rocket One Inc. focuses on developing and commercializing AI semiconductor infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
DARE vs RKTO FAQ
Which is bigger, Dare Bioscience or Rocket One?
Rocket One (RKTO) is larger, with a market capitalization of $16.55M compared with $15.37M for Dare Bioscience (DARE).
Which stock has performed better over the past year, DARE or RKTO?
RKTO returned -59.11% over the past 12 months, compared with -66.28% for DARE (price return, excluding dividends). Past performance does not predict future results.
Are Dare Bioscience and Rocket One in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.